Issues in patient-physician communication in CLL patients
FCR or FR – which regimen is better for treating CLL?
Exploiting signalling pathways involved in CLL to develop novel therapies
Expert advice for CLL patients: get treatment at specialized CLL centers
Preliminary results of ibruntinib in combination with FCR chemotherapy for CLL